MedTrace Logo

The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal

NCT04788823 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-02-13

No results posted yet for this study

Summary

1. Determine impact of prednisone on semen parameters post vasectomy reversal (evaluated both using prednisone as a combined cohort as well as via 3 separate protocols).
2. Determine impact of prednisone on pregnancy rates post vasectomy reversal (evaluated both using prednisone as a combined cohort as well as via 3 separate protocols).
3. Assess adverse events with prednisone utilization

Conditions

  • Vasectomy Reversal

Interventions

DRUG

Prednisone

Treatment groups will be administered different dosages of Prednisone post vasectomy reversal.

Sponsors & Collaborators

  • Charitable Union for the Research and Education of Peyronie's Disease

    lead OTHER

Principal Investigators

  • Benjamin Green · The Male Fertility and Peyronie's Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-24
Primary Completion
2026-02-28
Completion
2026-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04788823 on ClinicalTrials.gov